The need for more real-world data-driven reviews and meta-analyses in haematology: an essential call
Author:
Open Access
- 18 August 2026
- journal article
- Published by BMJ in Considerations in Medicine
- Vol. 4 (1) , e000058
Abstract
Randomised controlled trials remain essential for establishing treatment efficacy in haematology, but they cannot fully represent the diversity of patients, care pathways, and resource constraints encountered in routine practice, particularly in low- and middle-income countries (LMICs). This commentary argues for an integrated evidence system that combines locally generated real-world data with fit-for-purpose evidence-synthesis methods to advance precision haematology. Routinely collected clinical, laboratory, treatment, toxicity, and outcome data can clarify real-world effectiveness, long-term safety, uncommon adverse events, and variations in access to care. However, credible real-world evidence requires standardised datasets, clearly defined causal questions, appropriate handling of confounding and missing data, transparent reporting, and robust governance. Different synthesis methods should be matched to specific questions: individual participant data meta-analysis can examine treatment-effect heterogeneity; network meta-analysis can compare multiple interventions; living systematic reviews can maintain evidence currency; and realist and meta-narrative reviews can explore context and implementation. Machine-learning and federated approaches may further strengthen evidence generation, but only after data quality, interoperability, validation, and clinical relevance have been established. Progress in LMICs will require sustained investment in registries, data managers, biostatisticians, secure infrastructure, and equitable international collaboration. Connecting trial evidence, real-world evidence, and appropriate evidence synthesis rather than treating them as competing approaches could make precision haematology more context-responsive, implementable, and equitable.Keywords
This publication has 13 references indexed in Scilit:
- Externally Controlled Studies Using Real-World Data in Patients With Hematological CancersJAMA Oncology, 2024
- Using real-world evidence in haematologyBest Practice & Research Clinical Haematology, 2024
- The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligenceBlood Reviews, 2022
- Reality check: Real-world evidence to support therapeutic development in hematologic malignanciesBlood Reviews, 2022
- Methods for the inclusion of real-world evidence in network meta-analysisBMC Medical Research Methodology, 2021
- Living systematic review: 1. Introduction—the why, what, when, and howJournal of Clinical Epidemiology, 2017
- Real-World Evidence — What Is It and What Can It Tell Us?New England Journal of Medicine, 2016
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.American Journal of Epidemiology, 2016
- RAMESES publication standards: realist synthesesBMC Medicine, 2013
- Meta-analysis of individual participant data: rationale, conduct, and reportingBMJ, 2010